Breaking News Instant updates and real-time market news.

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

, VSAR

Versartis

$21.60

-0.25 (-1.14%)

07:18
09/22/17
09/22
07:18
09/22/17
07:18

Ascendis Pharma price target raised to $65 from $36 at Wedbush

Wedbush analyst Liana Moussatos raised her price target for Ascendis Pharma (ASND) shares to $65 after Versartis (VSAR) said the Phase 3 Velocity trial testing somavaratan long-acting growth hormone as a treatment for pediatric growth hormone deficiency failed to meet its endpoint. Competitor somavaratan is no longer a threat to Ascendis, Moussatos tells investors in a research note. Her new price target reflects increased penetration due to reduced competition. Moussatos reiterates an Outperform rating on Ascendis. The stock in premarket trading is up 39%, or $10.71, to $38.45.

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

VSAR

Versartis

$21.60

-0.25 (-1.14%)

ASND Ascendis Pharma
$27.74

-1.55 (-5.29%)

09/22/17
JPMS
09/22/17
NO CHANGE
JPMS
Overweight
One less competitor 'clear positive' for Ascendis, says JPMorgan
JPMorgan analyst Jessica Fye expects shares of Ascendis Pharma (ASND) to rally 10%-plus after Versartis (VSAR) reported negative results from the Phase III Velocity study in pediatric growth hormone deficiency. One less competitor in this market is a "clear positive" for Ascendis, Fye tells investors in a research note. She believes Versartis' failure will be viewed as company-specific given the prior Phase II data for somvaratan. The analyst continues to see a "high probability of success" for Ascendis' TransCon hGH in pediatric growth hormone. The analyst has an Overweight rating on the shares.
09/22/17
WELS
09/22/17
NO CHANGE
Target $51
WELS
Outperform
Versartis failure bodes well for Ascendis Pharma, says Wells Fargo
Wells Fargo analyst Jim Birchenough reiterates an Outperform rating on Ascendis Pharma (ASND) after its competitor Versartis (VSAR) announced last night that its long-acting recombinant human growth hormone, somavaratan, failed to meet the primary endpoint of non-inferiority in a Phase 3 study in pediatric growth hormone deficiency. The analyst continues to see a "high likelihood of success" for Ascendis Pharma's unmodified TransCon GH, which he says appears superior to both somavaratan and short acting growth hormone. Birchenough has a $51 price target on Ascendis shares. The stock last night in after-hours trading jumped 42%, or $11.66, to $39.40.
09/01/17
LEER
09/01/17
NO CHANGE
Target $28
LEER
Market Perform
Ascendis shares could move 20% on Versartis data, says Leerink
Leerink analyst Joseph Schwartz believes shares of Ascendis Pharma (ASND) could move up or down 20% on Versartis' (VSAR) somavaratan data in September. The data may have important read-through for Ascendis since it may indicate how much of the long-acting growth hormone market TransCon hGH will need to compete for. The analyst notes his base case scenario has Ascendis shares remaining flat or trading slightly down on somavaratan efficacy, which is "noninferior to daily Genotropin and safety which is acceptable." Schwartz reiterates a Market Perform rating on Ascendis with a $28 price target.
05/11/17
05/11/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Methanex (MEOH) initiated with an Underperform at Bernstein. 2. PTC (PTC) initiated with an Outperform at Baird. 3. Pioneer Natural (PXD) assumed with an Overweight at Piper Jaffray. 4. Ascendis Pharma (ASND) initiated with an Overweight at JPMorgan. 5. Control4 (CTRL) initiated with a Hold at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
VSAR Versartis
$21.60

-0.25 (-1.14%)

09/22/17
COWN
09/22/17
DOWNGRADE
COWN
Market Perform
Versartis downgraded to Market Perform, price target slashed to $3 at Cowen
Cowen analyst Ken Cacciatore downgraded Versartis to Market Perform from Outperform and slashed its price target to $3 from $45 following the VELOCITY trial failure. The analyst removed somavaratan from his valuation and said shares will now trade based on proforma cash levels.
09/22/17
LEHM
09/22/17
DOWNGRADE
Target $4
LEHM
Underweight
Versartis downgraded to Underweight from Overweight at Barclays
Barclays analyst Geoff Meacham double downgraded Versartis to Underweight from Overweight and cut his price target for the shares to $4 from $28 after the Phase 3 Velocity trial of somavaratan missed its primary endpoint. The analyst does not see a path forward for the pediatric program and sees minimal residual value to the adult program. Piper Jafray this morning also downgraded Versartis.

TODAY'S FREE FLY STORIES

VECO

Veeco

$21.75

0.5 (2.35%)

05:18
10/24/17
10/24
05:18
10/24/17
05:18
Downgrade
Veeco rating change  »

Veeco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:16
10/24/17
10/24
05:16
10/24/17
05:16
Initiation
PQ Group initiated  »

PQ Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRTO

Criteo

$46.14

0.13 (0.28%)

, AAPL

Apple

$156.17

-0.08 (-0.05%)

05:15
10/24/17
10/24
05:15
10/24/17
05:15
Downgrade
Criteo, Apple rating change  »

Criteo downgraded to…

CRTO

Criteo

$46.14

0.13 (0.28%)

AAPL

Apple

$156.17

-0.08 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 02

    Nov

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:10
10/24/17
10/24
05:10
10/24/17
05:10
Initiation
PQ Group initiated  »

PQ Group initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROX

Tronox

$26.58

0.25 (0.95%)

05:08
10/24/17
10/24
05:08
10/24/17
05:08
Initiation
Tronox initiated  »

Tronox initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:06
10/24/17
10/24
05:06
10/24/17
05:06
Initiation
PQ Group initiated  »

PQ Group initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARNC

Arconic

$24.35

-2.82 (-10.38%)

05:04
10/24/17
10/24
05:04
10/24/17
05:04
Recommendations
Arconic analyst commentary  »

Arconic selloff yesterday…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:01
10/24/17
10/24
05:01
10/24/17
05:01
Initiation
PQ Group initiated  »

PQ Group initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ON

ON Semiconductor

$20.08

0.01 (0.05%)

04:59
10/24/17
10/24
04:59
10/24/17
04:59
Recommendations
ON Semiconductor analyst commentary  »

ON Semiconductor price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

TECH

Bio-Techne

$123.88

-0.37 (-0.30%)

04:58
10/24/17
10/24
04:58
10/24/17
04:58
Recommendations
Bio-Techne analyst commentary  »

Bio-Techne price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 30

    Nov

ABT

Abbott

$56.08

-0.24 (-0.43%)

, DXCM

Dexcom

$44.77

-0.01 (-0.02%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Leerink medical devices analysts hold an analyst/industry conference call »

Analysts discuss…

ABT

Abbott

$56.08

-0.24 (-0.43%)

DXCM

Dexcom

$44.77

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 01

    Nov

  • 06

    Nov

JPM

JPMorgan

$99.34

-0.17 (-0.17%)

, C

Citi

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
eSHOW to hold a conference »

Money 20/20 is being held…

JPM

JPMorgan

$99.34

-0.17 (-0.17%)

C

Citi

CSCO

Cisco

$34.35

0.1 (0.29%)

BLK

BlackRock

$474.39

-2.23 (-0.47%)

BX

Blackstone

$34.72

0.26 (0.75%)

B

Barnes Group

$70.96

-0.93 (-1.29%)

BCS

Barclays

$10.27

-0.04 (-0.39%)

AMZN

Amazon.com

$966.30

-16.61 (-1.69%)

AKAM

Akamai

$51.46

-0.41 (-0.79%)

CS

Credit Suisse

$16.04

-0.06 (-0.37%)

DFS

Discover

$66.84

0.27 (0.41%)

IBM

IBM

$159.55

-2.52 (-1.55%)

INTC

Intel

$40.83

0.4 (0.99%)

SSNLF

Samsung

PAY

Verifone

$19.85

-0.21 (-1.05%)

MA

MasterCard

$145.56

0.18 (0.12%)

SPLK

Splunk

$64.23

0.14 (0.22%)

V

Visa

$107.53

-0.02 (-0.02%)

WFC

Wells Fargo

$54.91

-0.01 (-0.02%)

GOOG

Alphabet

$968.45

-19.75 (-2.00%)

MSFT

Microsoft

$78.83

0.02 (0.03%)

WMT

Wal-Mart

$88.65

1.21 (1.38%)

GS

Goldman Sachs

$242.13

-2.6 (-1.06%)

FB

Facebook

$171.27

-3.71 (-2.12%)

RY

Royal Bank of Canada

$80.19

-0.07 (-0.09%)

T

AT&T

$35.25

-0.29 (-0.82%)

JEF

Bought by LUK

ADBE

Adobe

$172.16

-3.48 (-1.98%)

BAC

Bank of America

$27.16

-0.01 (-0.04%)

DB

Deutsche Bank

$16.63

-0.35 (-2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 27

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 05

    Nov

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

  • 16

    Nov

  • 17

    Nov

  • 21

    Nov

  • 29

    Nov

  • 29

    Nov

  • 11

    Dec

  • 14

    Dec

  • 15

    Jan

  • 20

    Feb

  • 27

    Feb

  • 18

    Mar

  • 13

    Apr

  • 04

    May

  • 14

    Jul

  • 12

    Oct

MRK

Merck

$63.40

-0.48 (-0.75%)

, TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.01

-0.055 (-0.20%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
World Congress to hold a summit »

5th Annual Patient…

MRK

Merck

$63.40

-0.48 (-0.75%)

TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.01

-0.055 (-0.20%)

PFE

Pfizer

$36.40

-0.02 (-0.05%)

AGN

Allergan

$187.77

-0.51 (-0.27%)

ONCE

Spark Therapeutics

$83.69

1.82 (2.22%)

PODD

Insulet

$61.02

-0.56 (-0.91%)

ACHN

Achillion

$4.01

-0.14 (-3.37%)

SNY

Sanofi

$49.62

0.11 (0.22%)

ABEO

Abeona Therapeutics

$18.60

-0.4 (-2.11%)

JNJ

Johnson & Johnson

$143.62

1.22 (0.86%)

AZN

AstraZeneca

$34.39

-0.23 (-0.66%)

SHPG

Shire

$144.78

-0.47 (-0.32%)

GSK

GlaxoSmithKline

$40.62

-0.22 (-0.54%)

BMY

Bristol-Myers

$63.75

-0.67 (-1.04%)

SCMP

Sucampo

$10.10

-0.2 (-1.94%)

PCRX

Pacira

$32.95

-0.55 (-1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 27

    Oct

  • 28

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 09

    Nov

  • 09

    Nov

  • 16

    Nov

  • 30

    Nov

  • 12

    Jan

  • 02

    Feb

  • 05

    Mar

  • 06

    Apr

FSBK

First South Bancorp

$18.99

0.33 (1.77%)

, CARO

Carolina Financial

$36.80

0.63 (1.74%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Carolina Financial to host special shareholder meeting »

Special Shareholder…

FSBK

First South Bancorp

$18.99

0.33 (1.77%)

CARO

Carolina Financial

$36.80

0.63 (1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 26

    Oct

ASOMY

ASOS

$73.88

-0.4 (-0.54%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
ASOS management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

AQXP

Aquinox

$12.47

-0.27 (-2.12%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Aquinox management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 07

    Dec

DDAIF

Daimler AG

$80.60

0.03 (0.04%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Daimler AG management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

PAY

Verifone

$19.85

-0.21 (-1.05%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Verifone management to meet with Craig-Hallum »

Meeting to be held in Las…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 14

    Dec

04:55
10/24/17
10/24
04:55
10/24/17
04:55
General news
Breaking General news story  »

Week of 10/21 Redbook to…

04:55
10/24/17
10/24
04:55
10/24/17
04:55
General news
PMI Composite Flash â€' Level to be reported at 09:45 »

October PMI Composite…

MTNB

Matinas BioPharma

$1.15

-0.08 (-6.50%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Matinas BioPharma management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
The U.S. Commodity Futures Trading Commission holds a symposium »

25th Annual Symposium is…

SNY

Sanofi

$49.62

0.11 (0.22%)

, TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.01

-0.055 (-0.20%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Worldwide Business Research to hold a summit »

BioNetwork Partnering…

SNY

Sanofi

$49.62

0.11 (0.22%)

TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.01

-0.055 (-0.20%)

UNH

UnitedHealth

$207.01

-0.48 (-0.23%)

NVS

Novartis

$85.91

0.17 (0.20%)

HZNP

Horizon Pharma

$13.86

-0.23 (-1.63%)

ABBV

AbbVie

$94.51

-1.59 (-1.65%)

BAYRY

Bayer

$34.51

-0.29 (-0.83%)

MRK

Merck

$63.40

-0.48 (-0.75%)

RDHL

RedHill Biopharma

$9.11

-0.14 (-1.51%)

NBRV

Nabriva Therapeutics

$6.07

-0.26 (-4.11%)

PFE

Pfizer

$36.40

-0.02 (-0.05%)

TEVA

Teva

$14.54

-0.36 (-2.42%)

GILD

Gilead

$80.17

-1.04 (-1.28%)

ALXN

Alexion

$135.20

-3.82 (-2.75%)

GSK

GlaxoSmithKline

$40.62

-0.22 (-0.54%)

REGN

Regeneron

$432.76

-0.22 (-0.05%)

CELG

Celgene

$122.37

1.04 (0.86%)

LLY

Eli Lilly

$87.18

-0.05 (-0.06%)

AMGN

Amgen

$180.53

-2.43 (-1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 27

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 31

    Oct

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 08

    Nov

  • 09

    Nov

  • 13

    Nov

  • 16

    Nov

  • 16

    Nov

  • 30

    Nov

  • 30

    Nov

  • 02

    Dec

  • 04

    Dec

  • 02

    Feb

  • 03

    Feb

  • 12

    Feb

  • 30

    Apr

  • 17

    May

  • 28

    May

04:55
10/24/17
10/24
04:55
10/24/17
04:55
General news
Breaking General news story  »

4-Week Bill Auction to be…

OMN

Omnova Solutions

$11.40

0.4 (3.64%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Omnova Solutions management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.